It is then clear that PKCδ is engaged in so many and complex different processes (e.g., regulation of cell cycle, motility and metastasis diffusion) that it might hardly represent a feasible tumor-associated therapeutic target. The gene discussed is PRKCD; the disease is neoplasm.